EGFR and lung cancer: In nonsmall cell lung cancer (NSCLC) without EGFR mutation, afatinib was shown to induce apoptosis via Ets-like-1 protein (Elk-1)-mediated inhibition of cancerous inhibitor of PP2A (CIP2A) [12].